ts_code,end_date,bz_item,bz_code,bz_sales,bz_profit,bz_cost,curr_type
300363.SZ,20250630,其他业务,P,5806989.26,4396034.96,1410954.3,CNY
300363.SZ,20250630,临床后期及商业化业务,P,1082553188.2,444941433.95,637611754.25,CNY
300363.SZ,20250630,新兴业务(行业),I,115169184.71,-108264725.05,223433909.76,CNY
300363.SZ,20250630,小分子原料药业务,I,1499960712.92,551654801.34,948305911.58,CNY
300363.SZ,20250630,其他业务(行业),I,5806989.26,4396034.96,1410954.3,CNY
300363.SZ,20250630,其他业务(地区),D,0.14,,,CNY
300363.SZ,20250630,中国港澳台地区及海外地区,D,1152921042.36,463592136.99,689328905.37,CNY
300363.SZ,20250630,中国大陆,D,468015844.39,-15806025.64,483821870.03,CNY
300363.SZ,20250630,临床早期业务,P,417407524.72,106713367.39,310694157.33,CNY
300363.SZ,20250630,新兴业务,P,115169184.71,-108264725.05,223433909.76,CNY
300363.SZ,20241231,中国大陆,D,783419479.95,-60373497.05,843792977.0,CNY
300363.SZ,20241231,小分子原料药业务,I,2739611646.21,896914681.0,1842696965.21,CNY
300363.SZ,20241231,新兴业务(行业),I,242559405.5,-174325661.83,416885067.33,CNY
300363.SZ,20241231,新兴业务,P,242559405.5,-174325661.83,416885067.33,CNY
300363.SZ,20241231,中国港澳台地区及海外地区,D,2228546874.37,800978662.4,1427568211.97,CNY
300363.SZ,20241231,临床早期业务,P,729544523.7,104761893.75,624782629.95,CNY
300363.SZ,20241231,其他收入,P,29795302.61,18016146.18,11779156.43,CNY
300363.SZ,20241231,其他行业,I,29795302.61,18016146.18,11779156.43,CNY
300363.SZ,20241231,临床后期及商业化业务,P,2010067122.51,792152787.25,1217914335.26,CNY
300363.SZ,20240630,港澳台地区及海外地区,D,935890968.72,299096835.66,636794133.06,CNY
300363.SZ,20240630,中国大陆,D,416190415.94,-44663567.82,460853983.76,CNY
300363.SZ,20240630,临床早期业务,P,342767214.37,21652109.95,321115104.42,CNY
300363.SZ,20240630,临床后期及商业化业务,P,957014461.99,363458909.87,593555552.12,CNY
300363.SZ,20240630,医药定制研发生产(行业),I,1316917804.03,302958805.24,1013958998.79,CNY
300363.SZ,20240630,其他业务,P,52299708.3,-130677751.98,182977460.28,CNY
300363.SZ,20231231,港澳台地区及海外地区,D,2812083230.21,1421200349.6,1390882880.61,CNY
300363.SZ,20231231,其他行业,I,64297552.39,-43880910.76,108178463.15,CNY
300363.SZ,20231231,临床早期业务,P,644586477.25,54308203.19,590278274.06,CNY
300363.SZ,20231231,其他收入,P,149913895.54,-46371359.47,196285255.01,CNY
300363.SZ,20231231,临床后期及商业化业务,P,2872916749.7,1484267181.5,1388649568.2,CNY
300363.SZ,20231231,医药定制研发生产(行业),I,3603119570.1,1536084935.98,2067034634.12,CNY
300363.SZ,20231231,中国大陆,D,855333892.28,71003675.62,784330216.66,CNY
300363.SZ,20230630,临床后期及商业化业务,P,1988773673.67,1079094320.06,909679353.61,CNY
300363.SZ,20230630,临床早期业务,P,296794829.19,50842516.44,245952312.75,CNY
300363.SZ,20230630,其他业务,P,53177954.85,-30893540.8,84071495.65,CNY
300363.SZ,20230630,医药定制研发生产(行业),I,2315455497.66,1108009797.01,1207445700.65,CNY
300363.SZ,20230630,港澳台地区及海外地区,D,1988923572.75,1060270183.52,928653389.23,CNY
300363.SZ,20230630,中国大陆,D,349822884.96,38773112.18,311049772.78,CNY
300363.SZ,20221231,临床早期业务,P,613296056.2,,,CNY
300363.SZ,20221231,临床后期及商业化业务,P,6282219788.22,3569244104.18,2712975684.04,CNY
300363.SZ,20221231,医药定制研发生产(行业),I,6955672121.48,3654535522.63,3301136598.85,CNY
300363.SZ,20221231,港澳台地区及海外地区,D,6322166084.77,3576563115.23,2745602969.54,CNY
300363.SZ,20221231,其他收入,P,139285209.69,,,CNY
300363.SZ,20221231,其他业务(行业),I,79128932.63,708364.18,78420568.45,CNY
300363.SZ,20221231,中国大陆,D,712634969.34,78680771.59,633954197.75,CNY
300363.SZ,20221231,其他业务(地区),D,,,0.01,CNY
300363.SZ,20221231,其他行业,I,79128932.63,708364.18,78420568.45,CNY
300363.SZ,20220630,医药定制研发生产(行业),I,3898402190.76,2063609980.61,1834792210.15,CNY
300363.SZ,20220630,其他业务(地区),D,-0.02,-0.01,-0.01,CNY
300363.SZ,20220630,中国大陆,D,234394831.84,-18961632.1,253356463.94,CNY
300363.SZ,20220630,港澳台地区及海外地区,D,3679620488.58,2068516192.49,1611104296.09,CNY
300363.SZ,20220630,临床后期及商业化业务,P,3579842323.7,2025004483.93,1554837839.77,CNY
300363.SZ,20220630,医药定制研发生产业务(行业),I,3898402190.76,2063609980.61,1834792210.15,CNY
300363.SZ,20220630,其他业务,P,334172996.7,24550076.45,309622920.25,CNY
300363.SZ,20220630,港澳台地区及海外地区,D,3679620488.56,2068516192.48,1611104296.08,CNY
300363.SZ,20211231,医药定制研发生产(行业),I,3089399794.49,1327223495.73,1762176298.76,CNY
300363.SZ,20211231,临床后期及商业化业务,P,2038566810.06,856683204.48,1181883605.58,CNY
300363.SZ,20211231,医药定制研发生产业务(行业),I,3089399794.49,1327223495.73,1762176298.76,CNY
300363.SZ,20211231,其他业务(行业),I,15749835.19,-42914403.73,58664238.92,CNY
300363.SZ,20211231,其他收入,P,93699254.9,-39999435.04,133698689.94,CNY
300363.SZ,20211231,中国大陆,D,679030584.25,194060783.0,484969801.25,CNY
300363.SZ,20211231,港澳台地区及海外地区,D,2426119045.43,1090248309.0,1335870736.43,CNY
300363.SZ,20211231,其他行业,I,15749835.19,-42914403.73,58664238.92,CNY
300363.SZ,20211231,临床早期业务,P,972883564.72,467625322.56,505258242.16,CNY
300363.SZ,20210630,港澳台地区及海外地区,D,922674446.6,396805420.2,525869026.4,CNY
300363.SZ,20210630,医药定制研发生产业务(行业),I,1248913633.58,539104895.76,709808737.82,CNY
300363.SZ,20210630,中国大陆,D,333144376.79,142941852.77,190202524.02,CNY
300363.SZ,20210630,临床后期及商业化业务,P,863277809.81,352127977.14,511149832.67,CNY
300363.SZ,20210630,临床早期业务,P,359428188.64,171148125.13,188280063.51,CNY
300363.SZ,20210630,医药定制研发生产(行业),I,1248913633.58,539104895.76,709808737.82,CNY
300363.SZ,20210630,其他业务,P,33112824.94,16471521.14,16641303.8,CNY
300363.SZ,20210630,其他业务(地区),D,,,-350.44,CNY
300363.SZ,20201231,其他收入,P,58462841.9,22798364.3,35664477.6,CNY
300363.SZ,20201231,医药定制研发生产业务(行业),I,2032420039.57,857257861.37,1175162178.2,CNY
300363.SZ,20201231,港澳台地区及海外地区,D,1748428676.52,741499128.0,1006929548.52,CNY
300363.SZ,20201231,中国大陆,D,323446745.28,122028770.45,201417974.83,CNY
300363.SZ,20201231,临床早期业务,P,564466910.86,250216805.89,314250104.97,CNY
300363.SZ,20201231,临床后期及商业化业务,P,1448945669.04,590512728.26,858432940.78,CNY
300363.SZ,20201231,医药定制研发生产(行业),I,2032420039.57,857257861.37,1175162178.2,CNY
300363.SZ,20200630,中国大陆,D,148342954.78,76819515.67,71523439.11,CNY
300363.SZ,20200630,其他业务,P,28024277.61,2330326.35,25693951.26,CNY
300363.SZ,20200630,医药定制研发生产(行业),I,900143423.88,354681773.03,545461650.85,CNY
300363.SZ,20200630,医药定制研发生产业务(行业),I,900143423.88,354681773.03,545461650.85,CNY
300363.SZ,20200630,临床早期业务,P,227678766.7,91341925.03,136336841.67,CNY
300363.SZ,20200630,港澳台地区及海外地区,D,776923026.28,280297921.42,496625104.86,CNY
300363.SZ,20200630,临床后期及商业化业务,P,669562936.79,263445185.77,406117751.02,CNY
300363.SZ,20191231,其他业务(地区),D,,,-0.03,CNY
300363.SZ,20191231,医药定制研发生产(行业),I,1510327968.46,582559409.25,927768559.21,CNY
300363.SZ,20191231,中国大陆,D,269220544.2,94228010.9,174992533.3,CNY
300363.SZ,20191231,其他业务(行业),I,40970793.81,4460311.56,36510482.25,CNY
300363.SZ,20191231,其他行业,I,40970793.81,4460311.56,36510482.25,CNY
300363.SZ,20191231,医药定制研发生产业务(行业),I,1510327968.46,582559409.25,927768559.21,CNY
300363.SZ,20191231,临床后期及商业化业务,P,1026775654.96,418835545.28,607940109.68,CNY
300363.SZ,20191231,临床早期业务,P,491289239.04,178897246.38,312391992.66,CNY
300363.SZ,20191231,港澳台地区及海外地区,D,1282078218.07,492791709.88,789286508.19,CNY
300363.SZ,20191231,其他收入,P,33233868.27,-10713070.85,43946939.12,CNY
300363.SZ,20190630,港澳台地区及海外地区,D,502550778.12,173817973.52,328732804.6,CNY
300363.SZ,20190630,临床后期及商业化业务,P,439414907.95,171794487.63,267620420.32,CNY
300363.SZ,20190630,医药定制研发生产业务(行业),I,620739599.49,230946175.42,389793424.07,CNY
300363.SZ,20190630,中国大陆,D,121973859.08,58181773.79,63792085.29,CNY
300363.SZ,20190630,医药定制研发生产(行业),I,620739599.49,230946175.42,389793424.07,CNY
300363.SZ,20190630,港澳台及海外,D,502550778.12,173817973.52,328732804.6,CNY
300363.SZ,20190630,其他业务,P,17518813.83,1765677.9,15753135.93,CNY
300363.SZ,20190630,临床早期业务,P,167590915.42,58439581.78,109151333.64,CNY
300363.SZ,20181231,中国大陆,D,258070818.83,99369798.14,158701020.69,CNY
300363.SZ,20181231,其他行业,I,45792042.74,13299881.83,32492160.91,CNY
300363.SZ,20181231,港澳台及海外,D,926792437.49,297120891.41,629671546.08,CNY
300363.SZ,20181231,临床后期及商业化业务,P,848250953.98,294678036.12,553572917.86,CNY
300363.SZ,20181231,临床早期业务,P,296212241.94,94810221.65,201402020.29,CNY
300363.SZ,20181231,其他收入,P,40400060.4,7002431.78,33397628.62,CNY
300363.SZ,20181231,港澳台地区及海外地区,D,926792437.49,297120891.41,629671546.08,CNY
300363.SZ,20181231,医药定制研发生产(行业),I,1139071213.58,383190807.72,755880405.86,CNY
300363.SZ,20181231,医药定制研发生产业务(行业),I,1139071213.58,383190807.72,755880405.86,CNY
300363.SZ,20181231,其他业务(行业),I,45792042.74,13299881.83,32492160.91,CNY
300363.SZ,20180630,医药定制研发生产(行业),I,492533341.52,174308337.84,318225003.68,CNY
300363.SZ,20180630,临床后期及商业化业务,P,352257117.01,121334007.3,230923109.71,CNY
300363.SZ,20180630,港澳台及海外,D,354842259.82,126059543.32,228782716.5,CNY
300363.SZ,20180630,其他业务,P,18401269.05,2623361.37,15777907.68,CNY
300363.SZ,20180630,港澳台地区及海外地区,D,354842259.82,126059543.32,228782716.5,CNY
300363.SZ,20180630,临床早期业务,P,139311927.3,54298510.5,85013416.8,CNY
300363.SZ,20180630,医药定制研发生产业务(行业),I,492533341.52,174308337.84,318225003.68,CNY
300363.SZ,20180630,中国大陆,D,155128053.54,52196335.85,102931717.69,CNY
300363.SZ,20171231,医药定制研发生产业务(行业),I,977481805.06,388517378.11,588964426.95,CNY
300363.SZ,20171231,中国大陆,D,174033818.32,44711611.48,129322206.84,CNY
300363.SZ,20171231,其他产品,P,65676400.43,17830576.01,47845824.42,CNY
300363.SZ,20171231,临床后期及商业化业务,P,927788389.77,358732293.59,569056096.18,CNY
300363.SZ,20171231,医药定制研发生产(行业),I,977481805.06,388517378.11,588964426.95,CNY
300363.SZ,20171231,港澳台地区及海外地区,D,1010054948.97,390380046.1,619674902.87,CNY
300363.SZ,20171231,医药化工商贸收入,I,41771013.06,3724988.45,38046024.61,CNY
300363.SZ,20171231,其他收入(行业),P,65676400.43,17830576.01,47845824.42,CNY
300363.SZ,20171231,多客户产品生产业务(行业),I,150874449.31,41819815.51,109054633.8,CNY
300363.SZ,20171231,其他收入,P,65676400.43,17830576.01,47845824.42,CNY
300363.SZ,20171231,临床早期业务,P,190623977.09,58528787.98,132095189.11,CNY
300363.SZ,20171231,港澳台及海外,D,1010054948.97,390380046.1,619674902.87,CNY
300363.SZ,20170630,其他业务(地区),D,48809448.3,13571979.6,35237468.7,CNY
300363.SZ,20170630,其他业务,P,243687597.99,74382648.32,169304949.67,CNY
300363.SZ,20170630,医药定制研发生产业务(行业),I,477521192.2,198880277.0,278640915.2,CNY
300363.SZ,20170630,抗病毒,P,349561803.78,154754428.52,194807375.26,CNY
300363.SZ,20170630,欧洲,D,313614257.15,119590569.57,194023687.58,CNY
300363.SZ,20170630,北美洲,D,153281851.47,77728129.5,75553721.97,CNY
300363.SZ,20170630,中国大陆,D,77543844.85,18246398.17,59297446.68,CNY
300363.SZ,20170630,多客户产品生产业务(行业),I,72192652.95,24053622.72,48139030.23,CNY
300363.SZ,20170630,港澳台及海外,D,466896108.62,197318699.07,269577409.55,CNY
300363.SZ,20170630,医药定制研发生产(行业),I,477521192.2,198880277.0,278640915.2,CNY
300363.SZ,20170630,医药定制研发生产业务,P,349561803.78,154754428.52,194807375.26,CNY
300363.SZ,20170630,港澳台地区及海外地区,D,466896108.62,197318699.07,269577409.55,CNY
300363.SZ,20161231,抗病毒,P,760456056.44,332622364.23,427833692.21,CNY
300363.SZ,20161231,降血脂类,P,92701706.09,,,CNY
300363.SZ,20161231,医药定制研发生产业务(行业),I,1079565844.23,498062406.49,581503437.74,CNY
300363.SZ,20161231,多客户产品生产业务(行业),I,191552319.54,22776122.46,168776197.08,CNY
